<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>viral-and-autoimmune-hepatitis</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="viral-and-autoimmune-hepatitis_files/libs/clipboard/clipboard.min.js"></script>
<script src="viral-and-autoimmune-hepatitis_files/libs/quarto-html/quarto.js"></script>
<script src="viral-and-autoimmune-hepatitis_files/libs/quarto-html/popper.min.js"></script>
<script src="viral-and-autoimmune-hepatitis_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="viral-and-autoimmune-hepatitis_files/libs/quarto-html/anchor.min.js"></script>
<link href="viral-and-autoimmune-hepatitis_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="viral-and-autoimmune-hepatitis_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="viral-and-autoimmune-hepatitis_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="viral-and-autoimmune-hepatitis_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="viral-and-autoimmune-hepatitis_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CViral-and-Autoimmune-Hepatitis0.jpg" class="img-fluid"></p>
<section id="viral-and-autoimmune-hepatitis" class="level1">
<h1>Viral and Autoimmune Hepatitis</h1>
</section>
<section id="serdar-balci-md" class="level1">
<h1>Serdar BALCI, MD</h1>
</section>
<section id="viral-hepatitis" class="level1">
<h1>VIRAL HEPATITIS</h1>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis1.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis2.png" class="img-fluid"></p>
<p><strong>MacSween’s Pathology of the Liver 6th Ed</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis3.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis4.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis5.png" class="img-fluid"></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis6.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis7.png" class="img-fluid"></p>
<p><strong>The risk of hepatocellular carcinoma</strong></p>
<p><strong>0.02% per year for chronic hepatitis B</strong></p>
<p><strong>2.5% per year when cirrhosis has developed</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="hepatitis-b" class="level1">
<h1>Hepatitis B</h1>
<p><strong>HBV replication does not involve the integration of the virus in the DNA of the host cell</strong></p>
<p><strong>Integrated HBV frequently is found in cells</strong></p>
<p><strong>The integrated viruses generally have large deletions and rearrangements and usually become inactive</strong></p>
<ul>
<li><strong>HBcAg</strong>
<ul>
<li><strong>The precore/core region of a nucleocapsid “core” protein, the hepatitis B core antigen</strong></li>
<li><strong>retained in the infected hepatocyte</strong></li>
</ul></li>
<li><strong>HBeAg</strong>
<ul>
<li><strong>a precore protein</strong></li>
<li><strong>secreted into blood and is essential for the establishment of persistent infection</strong></li>
</ul></li>
<li><strong>HBsAg</strong>
<ul>
<li><strong>Envelope glycoprotein</strong></li>
<li><strong>surface antigen</strong></li>
<li><strong>produced and secreted into the blood in massive amounts</strong></li>
<li><strong>Blood HBsAg is immunogenic</strong></li>
</ul></li>
<li><strong>A DNA polymerase</strong>
<ul>
<li><strong>error-prone reverse transcriptase activity</strong></li>
<li><strong>generates mutations in the genomes of replicating virus at a high rate</strong></li>
</ul></li>
<li><strong>HBV-X protein</strong>
<ul>
<li><strong>transcriptional transactivator for many viral and host genes</strong></li>
<li><strong>required for viral infectivity</strong></li>
<li><strong>may have a role in the development of hepatocellular carcinoma by regulating p53 degradation and expression</strong></li>
</ul></li>
</ul>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis8.png" class="img-fluid"></p>
<p><strong>MacSween’s Pathology of the Liver 6th Ed</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis9.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis10.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Innate immunity protects the host during the initial phases of the infection</strong></p>
<p><strong>A strong response by virus-specific CD4+ and CD8+ interferon γ–producing cells is associated with the resolution of acute infection</strong></p>
<p><strong>HBV does not cause direct hepatocyte injury</strong></p>
<p><strong>Hepatocyte damage results from killing of the virus-infected cells by CD8+ cytotoxic T cells</strong></p>
<p><strong>Chronic HBV infection</strong></p>
<p><strong>Some hepatocytes may have viral genomes integrated into the host genome</strong></p>
<p><strong>If surface antigen gene integrates cell produces it</strong></p>
<p><strong>Usually in such cells full viral replication does not take place</strong></p>
<p><strong>The antigen just accumulates in these cells</strong></p>
<p><strong>Large cytoplasmic inclusion consisting of endoplasmic reticulum stuffed with surface antigen </strong></p>
<p><strong>Fine, smoothly granular appearance similar to that of ground glass</strong></p>
<p><strong>Rosai and Ackerman’s Surgical Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis11.png" class="img-fluid"></p>
<p><strong>Chronic viral hepatitis B: viral replicative phase. Hepatitis B core antigen </strong></p>
<p><strong>Rosai and Ackerman’s Surgical Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis12.png" class="img-fluid"></p>
<p><strong>Chronic viral hepatitis B: viral replicative phase. Hepatitis B surface antigen </strong></p>
<p><strong>Rosai and Ackerman’s Surgical Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis13.png" class="img-fluid"></p>
<p><strong>Chronic viral hepatitis B: viral nonreplicative (integration) phase. Hepatitis B surface antigen </strong></p>
<p><strong>Ground-glass hepatocytes in chronic hepatitis B, caused by accumulation of HBsAg in cytoplasm, have large, pale, finely granular, pink cytoplasmic inclusions on hematoxylin-eosin staining</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis14.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis15.png" class="img-fluid"></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis16.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="hepatitis-c" class="level1">
<h1>Hepatitis C</h1>
<p><strong>Subclassified into six genotypes, based on the genetic sequence</strong></p>
<p><strong>Infected person may carry many HCV variants</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis17.png" class="img-fluid"></p>
<p><strong>The risk of hepatocellular carcinoma is 1% to 4% per year</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Anti-HCV antibodies develop within weeks to a few months, they do not confer effective immunity</strong></p>
<p><strong>Strong immune responses involving CD4+ and CD8+ cells are associated with self-limited HCV infections</strong></p>
<p><strong>It is not known why only a minority of persons are capable of clearing HCV infection</strong></p>
<p><strong>Persistent infection is the hallmark of HCV infection, occurring in 80% to 85% of patients with subclinical or asymptomatic acute infection</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis18.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis19.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Typical features of chronic hepatitis</strong></li>
<li><strong>Fatty change</strong>
<ul>
<li><strong>Altered lipid metabolism in infected hepatocytes</strong></li>
<li><strong>Insulin resistance</strong></li>
</ul></li>
<li><strong>Lymphoid infiltrates in portal tracts, sometimes with fully formed lymphoid follicles</strong></li>
<li><strong>Bile duct injury</strong>
<ul>
<li><strong>Direct infection of cholangiocytes by the virus</strong></li>
</ul></li>
</ul>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis20.png" class="img-fluid"></p>
</section>
<section id="section" class="level1">
<h1></h1>
<p><strong>In HBV and HCV infection, circulating antibody-antigen complexes produce immune-complex disease in the form of vasculitis (subcutaneous or visceral) and glomerulonephritis</strong></p>
<p><strong>Cryoglobulinemia is found in 50% of patients with hepatitis C</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis21.png" class="img-fluid"></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis22.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="hepatitis-d-virus" class="level1">
<h1>Hepatitis D Virus</h1>
<ul>
<li><strong>Delta hepatitis virus</strong></li>
<li><strong>Arises in two settings</strong></li>
<li><strong>Acute coinfection after exposure to serum containing both HDV and HBV</strong>
<ul>
<li><strong>Most coinfected persons clear the viruses and recover completely</strong></li>
</ul></li>
<li><strong>Superinfection of a chronic carrier of HBV with a new inoculum of HDV</strong>
<ul>
<li><strong>Most superinfected persons there is an acceleration of hepatitis, progressing to more severe chronic hepatitis 4 to 7 weeks later</strong></li>
</ul></li>
</ul>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis23.png" class="img-fluid"></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis24.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="hepatitis-e" class="level1">
<h1>Hepatitis E</h1>
<p><strong>HEV hepatitis is an enterically transmitted, waterborne infection occurring primarily beyond the years of infancy</strong></p>
<p><strong>Endemic in India</strong></p>
<p><strong>Epidemics from Asia, sub-Saharan Africa, and Mexico</strong></p>
<p><strong>Sporadic infection seems to be uncommon</strong></p>
<p><strong>In most cases, the disease is self-limited; not associated with chronic liver disease or persistent viremia</strong></p>
<p><strong>High mortality rate among pregnant women, approaching 20%</strong></p>
</section>
<section id="clinical-features-and-outcomes-for-viral-hepatitis" class="level1">
<h1>Clinical Features and Outcomes for Viral Hepatitis</h1>
<ul>
<li><strong>A number of clinical syndromes may develop after exposure to hepatitis viruses</strong></li>
<li><strong>Asymptomatic acute infection</strong>
<ul>
<li><strong>Serologic evidence only</strong></li>
</ul></li>
<li><strong>Acute hepatitis</strong>
<ul>
<li><strong>Anicteric or icteric</strong></li>
</ul></li>
<li><strong>Fulminant hepatitis</strong>
<ul>
<li><strong>Submassive to massive hepatic necrosis with acute liver failure</strong></li>
</ul></li>
<li><strong>Chronic hepatitis</strong>
<ul>
<li><strong>With or without progression to cirrhosis</strong></li>
</ul></li>
<li><strong>Chronic carrier state</strong>
<ul>
<li><strong>Asymptomatic without apparent disease</strong></li>
</ul></li>
</ul>
</section>
<section id="other-viral-infections-of-the-liver" class="level1">
<h1>Other Viral Infections of the Liver</h1>
<ul>
<li><strong>Epstein-Barr virus (EBV)</strong>
<ul>
<li><strong>mild hepatitis during the acute phase of infectious mononucleosis</strong></li>
</ul></li>
<li><strong>Cytomegalovirus infection</strong>
<ul>
<li><strong>newborn or immunocompromised</strong></li>
<li><strong>typical cytomegalic changes of that virus in almost any cell of the liver, hepatocytes, cholangiocytes, and endothelial cells</strong></li>
</ul></li>
<li><strong>Herpes simplex</strong>
<ul>
<li><strong>infect hepatocytes in newborns or the immunosuppressed</strong></li>
<li><strong>appearance of the characteristic cytopathic changes and hepatic necrosis</strong></li>
</ul></li>
<li><strong>Yellow fever</strong>
<ul>
<li><strong>major and serious cause of hepatitis in tropical countries</strong></li>
<li><strong>causes hepatocyte apoptosis, can be extensive</strong></li>
<li><strong>Apoptotic hepatocytes are intensely eosinophilic, Councilman bodies</strong></li>
</ul></li>
<li><strong>Rubella virus, adenovirus, or enterovirus infections</strong>
<ul>
<li><strong>Infants, immunosuppressed</strong></li>
</ul></li>
</ul>
<p><strong>EBV</strong></p>
<p><strong>CMV</strong></p>
<p><strong>HSV</strong></p>
<p><strong>Yellow fever</strong></p>
<p><strong>Rubella</strong></p>
<p><strong>Adenovirus</strong></p>
<p><strong>Enterovirus</strong></p>
</section>
<section id="liver-abscesses" class="level1">
<h1>Liver Abscesses</h1>
<ul>
<li><strong>Amebic</strong></li>
<li><strong>Other protozoal and helminthic organisms</strong></li>
<li><strong>Bacterial abscesses</strong>
<ul>
<li><strong>more common in developed countries</strong></li>
<li><strong>representing a complication of an infection elsewhere</strong></li>
</ul></li>
<li><strong>The organisms reach the liver:</strong>
<ul>
<li><strong>Ascending infection in the biliary tract (ascending cholangitis)</strong></li>
<li><strong>Vascular seeding, either portal or arterial, predominantly from the gastrointestinal tract</strong></li>
<li><strong>Direct invasion of the liver from a nearby source</strong></li>
<li><strong>A penetrating injury</strong></li>
</ul></li>
</ul>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis25.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>
<section id="granulomatous-disease" class="level1">
<h1>Granulomatous Disease</h1>
<p><strong>Fungal or acid-fast organisms</strong></p>
<p><strong>Systemic sarcoidosis</strong></p>
<p><strong>Duct destructive lesions in primary biliary cirrhosis</strong></p>
<p><strong>Parasites</strong></p>
<p><strong>Drug- or toxin-induced injury</strong></p>
</section>
<section id="autoimmune-hepatitis" class="level1">
<h1>AUTOIMMUNE HEPATITIS</h1>
</section>
<section id="autoimmune-hepatitis-1" class="level1">
<h1>Autoimmune Hepatitis</h1>
<ul>
<li><strong>Female predominance (70%)</strong></li>
<li><strong>No serologic evidence of viral infection</strong></li>
<li><strong>Elevated serum IgG (levels greater than 2.5 g/dL)</strong></li>
<li><strong>High titers of autoantibodies in 80% of cases</strong></li>
<li><strong>The presence of other forms of autoimmune diseases, seen in up to 60% of patients</strong>
<ul>
<li><strong>Rheumatoid arthritis, thyroiditis, Sjögren syndrome, and ulcerative colitis</strong></li>
</ul></li>
</ul>
<p><strong>Circulating antinuclear antibodies</strong></p>
<p><strong>Anti–smooth muscle antibodies</strong></p>
<p><strong>Liver/kidney microsomal antibody</strong></p>
<p><strong>Anti–soluble liver/pancreas antigen antibody</strong></p>
<ul>
<li><strong>Type 1</strong> <strong>: Patients have</strong>
<ul>
<li><strong>antinuclear (ANA)</strong></li>
<li><strong>anti-smooth muscle (SMA)</strong></li>
<li><strong>anti-actin (AAA)</strong></li>
<li><strong>anti-soluble liver antigen/liver-pancreas antigen (SLA/LP)</strong></li>
<li><strong>Associated with HLA-DR3</strong></li>
</ul></li>
<li><strong>Type 2</strong> <strong>: Patients have</strong>
<ul>
<li><strong>anti-liver kidney microsome-1 (ALKM-1)</strong></li>
<li><strong>anti-liver-cytosol-1 (ALC-1)</strong></li>
</ul></li>
<li><strong>Main effectors of cell damage in autoimmune hepatitis are believed to be CD4+ helper cells</strong></li>
<li><strong>Mononuclear infiltrate in autoimmune hepatitis frequently has abundant plasma cells</strong></li>
<li><strong>Mild to severe chronic hepatitis</strong></li>
<li><strong>Response to immunosuppressive therapy usually is dramatic, although a full remission of disease is unusual</strong></li>
<li><strong>The overall risk of cirrhosis is 5%</strong>
<ul>
<li><strong>main cause of death</strong></li>
</ul></li>
</ul>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis26.png" class="img-fluid"></p>
<p><strong>Early phase of severe cell injury and inflammation followed by rapid scarring</strong></p>
<p><strong>This early wave of hepatocyte damage and necrosis usually is subclinical</strong></p>
<p><strong>Clinical evolution correlates with a limited number of histologic patterns</strong></p>
<p><strong>Very severe hepatocyte injury associated with widespread confluent necrosis</strong></p>
<p><strong>Marked inflammation concurrent with advanced scarring</strong></p>
<p><strong>Burned-out cirrhosis, associated with little ongoing cell injury or inflammation</strong></p>
<p><img src="img%5CViral-and-Autoimmune-Hepatitis27.png" class="img-fluid"></p>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>